NCT Number: NCT05948657
Phase:
Trial Summary: This study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (AS) with low risk and favorable intermedi – see clinicaltrials.gov for information and location
Clinicaltrials.gov
Trial Sponsor(s): Weill Medical College of Cornell University
Acronym: ESCAPE
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives